Stockreport

Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk to Develop Novel Treatment for Dyslipidaemia

argenx SE - American Depositary Shares  (ARGX) 
PDF NAARDEN, The Netherlands & MUNICH--(BUSINESS WIRE)-- Forbion today announces that its portfolio company Staten Biotechnology B.V. and Novo Nordisk A/S have [Read more]